Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

RADIOMETER

Radiometer Medical develops, manufactures and markets solutions for blood sampling, blood gas analysis, transcutaneou... read more Featured Products: More products

Download Mobile App




Bench-Top Immunoanalyzer Evaluated for βhCG Assay

By LabMedica International staff writers
Posted on 28 Jan 2019
Rapid and accurate diagnosis of pregnancy complications that require acute care is frequently augmented by combining clinical assessment, medical history, and one or more quantitative human chorionic gonadotropin (hCG) results.

Many smaller suburban or rural hospitals have been unable to maintain an hCG assay on an automated, random-access immunoanalyzer in the laboratory. For one, the capital cost of such analyzers has been frequently prohibitive. Moreover, laboratories have not always had the space to accommodate such large analyzers and low testing volume has posed an additional challenge and has led to high overall cost-per-reportable test.

Medical Laboratory Scientists at the University of Alberta (Edmonton, AB, Canada) and their colleagues evaluated the analytical performance of the AQT90 hCG assay (Radiometer Medical ApS, Brønshøj, Denmark) and compared it to a point-of-care testing (POCT) assay and two central laboratory assays that are currently in clinical use in Edmonton, Canada. All patients whose samples were included in this study had had an hCG measured on them for clinical purposes. Precision was assessed using whole blood patient samples and two levels of quality control. Linearity was assessed by dilution of a high hCG plasma sample. Carryover and hook effect were assessed using high and low hCG samples.

Thirty-six patient samples were compared between the AQT90 and the Abbott i-STAT Total βhCG (Chicago, IL, USA), the Beckman Coulter Total βhCG (Brea, CA, USA) and the Roche hCG+β assays (Basel, Switzerland). Sample concentrations ranged from <2 IU/L to 4,973 IU/L. The Radiometer AQT90 FLEX is a small benchtop immunoassay analyzer for use in the laboratory or at the patient bedside.

The measurement principle of all AQT90 assays is based on an all-in-one dry-reagent concept. A test cartridge contains 16 reaction cups and is stable onboard the analyzer for 20 days. All required assay-specific reagents, including europium chelate-labeled tracer antibodies, biotinylated capture antibodies, and stabilizing reagents, are dry-coated into the reaction cups. The AQT90 hCG assay is intended for use as an aid in the early detection of pregnancy. It takes 18 minutes to complete, and its antibodies recognize both intact hCG and the free β subunit.

The results of this study suggest that the AQT90 performs comparably, or even better, to some other POCT hCG assays available in Canada. The i-STAT assay, for example, demonstrated a clinically acceptable precision profile and excellent correlation with central laboratory hCG assays in two different studies. The analytical measurement range of the AQT90 also appears more suitable to the investigation of early pregnancy complications than that of the i-STAT.

The authors concluded that overall, the AQT90 hCG assay performed well in their study, and the analytical data suggest that it would be suitable for use at smaller suburban or rural hospitals that are unable to maintain hCG assays on automated, random-access immunoanalyzers in the laboratory. The study was published on January 11, 2019, in the journal Practical Laboratory Medicine.


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Immunofluorescence Analyzer
MPQuanti
New
Troponin I Test
Quidel Triage Troponin I Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.